Alkaloid AD Logo

Alkaloid AD

Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.

ALK | MSE

Overview

Corporate Details

ISIN(s):
MKALKA101011
LEI:
Country:
North Macedonia
Address:
Blvd. Aleksandar Makedonski 12, 1000 Skopje
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alkaloid AD is a pharmaceutical company with over eight decades of experience in the manufacturing of drugs, cosmetics, and chemical products, as well as the processing of botanical raw materials. The company's operations are structured into two primary profit centers: Pharmacy, and Chemistry, Cosmetics, and Herbal Medicine. Its product portfolio encompasses a wide range of generic drugs, with a focus on oral solid dosage forms, alongside various cosmetic and herbal products. The company also engages in pharmaceutical innovation, holding an international patent for a value-added medicine, liquid Omeprazole. Alkaloid AD serves both healthcare professionals and the general consumer market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alkaloid AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkaloid AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkaloid AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT

Talk to a Data Expert

Have a question? We'll get back to you promptly.